Some studies on postmortem brain tissue from AD patients found a higher level of neurogenesis in the hippocampus [108], while other studies found that neurogenic markers like Musashi-1, Sox2, and doublecortin are downregulated in the brains of AD patients [109, 110]. This evidence concerns the gene SOX2 and Alzheimer disease.